110 related articles for article (PubMed ID: 21697240)
41. [Podocyte injury and glomerular sclerosis].
Matsusaka T
Nihon Rinsho; 2004 Oct; 62(10):1805-10. PubMed ID: 15500122
[TBL] [Abstract][Full Text] [Related]
42. Urinary podocytes in primary focal segmental glomerulosclerosis.
Hara M; Yanagihara T; Kihara I
Nephron; 2001 Nov; 89(3):342-7. PubMed ID: 11598401
[TBL] [Abstract][Full Text] [Related]
43. Cellular focal segmental glomerulosclerosis: Clinical and pathologic features.
Stokes MB; Valeri AM; Markowitz GS; D'Agati VD
Kidney Int; 2006 Nov; 70(10):1783-92. PubMed ID: 17021605
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical expression of podocyte markers in the variants of focal segmental glomerulosclerosis.
Testagrossa L; Azevedo Neto R; Resende A; Woronik V; Malheiros D
Nephrol Dial Transplant; 2013 Jan; 28(1):91-8. PubMed ID: 22859792
[TBL] [Abstract][Full Text] [Related]
45. Podocytes, parietal cells, and glomerular pathology: the role of cell cycle proteins.
Nagata M; Tomari S; Kanemoto K; Usui J; Lemley KV
Pediatr Nephrol; 2003 Jan; 18(1):3-8. PubMed ID: 12488982
[TBL] [Abstract][Full Text] [Related]
46. Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.
Darouich S; Goucha R; Jaafoura MH; Zekri S; Ben Maiz H; Kheder A
Ultrastruct Pathol; 2011 Aug; 35(4):176-82. PubMed ID: 21657818
[TBL] [Abstract][Full Text] [Related]
47. Two different pathways of glomerular enlargement in adults with focal and segmental glomerulosclerosis: a morphometric study.
Matsumae T; Fukuzaki M; Takebayashi S; Naito S
Am J Nephrol; 1998; 18(1):21-7. PubMed ID: 9481435
[TBL] [Abstract][Full Text] [Related]
48. Pathobiology of focal sclerosis.
Wolthuis A; van Goor H; Weening JJ; Grond J
Curr Opin Nephrol Hypertens; 1993 May; 2(3):458-64. PubMed ID: 7922206
[TBL] [Abstract][Full Text] [Related]
49. Crystalloid podocytopathy with focal segmental glomerulosclerosis in PCM: a case report.
Jeon YL; Lee WI; Choi Y; Kang SY; Kim MH; Lim SJ; Lee SH
Diagn Pathol; 2015 Dec; 10():213. PubMed ID: 26670310
[TBL] [Abstract][Full Text] [Related]
50. How does podocyte damage result in tubular damage?
Kriz W; Elger M; Hosser H; Hähnel B; Provoost A; Kränzlin B; Gretz N
Kidney Blood Press Res; 1999; 22(1-2):26-36. PubMed ID: 10352405
[TBL] [Abstract][Full Text] [Related]
51. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
52. Glomerulosclerosis: a paraneoplastic phenomenon?
Loi S; Perry GJ; Standish H; Dowling J
Nephrology (Carlton); 2004 Dec; 9(6):387-91. PubMed ID: 15663641
[TBL] [Abstract][Full Text] [Related]
53. [Mitochondrial dysfunction and focal segmental glomerular sclerosis].
Yamagata K; Hagiwara M; Koyama A
Nihon Rinsho; 2004 Oct; 62(10):1817-22. PubMed ID: 15500124
[TBL] [Abstract][Full Text] [Related]
54. Is vacuolization of podocytes and glomerular endothelial cells of prognostic value with respect to FSGS?
Salwa-Zurawska W; Woźniak A; Biczysko W; Bortkiewicz E; Kaczmarek E; Maciejewski J
Pol J Pathol; 1998; 49(3):165-74. PubMed ID: 9810176
[TBL] [Abstract][Full Text] [Related]
55. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
Kim JS; Han BG; Choi SO; Cha SK
Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
[TBL] [Abstract][Full Text] [Related]
56. Glomerular cells in the progression of human and experimental nephropathies.
Floege J; Gröne HJ
Adv Nephrol Necker Hosp; 1997; 27():15-37. PubMed ID: 9408440
[No Abstract] [Full Text] [Related]
57. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
Yang Y; Gubler MC; Beaufils H
Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471
[TBL] [Abstract][Full Text] [Related]
58. Up-Regulation of CD74 Expression in Parietal Epithelial Cells in a Mouse Model of Focal Segmental Glomerulosclerosis.
Yamazaki T; Sasaki S; Okamoto T; Sato Y; Hayashi A; Ariga T
Nephron; 2016; 134(4):238-252. PubMed ID: 27463800
[TBL] [Abstract][Full Text] [Related]
59. [Not Available].
Helmuth A; Huynh-Do U
Ther Umsch; 2015 Mar; 72(3):189-93. PubMed ID: 25722312
[TBL] [Abstract][Full Text] [Related]
60. Glomerular scarring: can we delay or even reverse glomerulosclerosis by RAAS inhibition?
Moeller MJ
Nephrol Dial Transplant; 2010 Jul; 25(7):2101-3. PubMed ID: 20388634
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
